Natural history and murine listeriosis model
============================================

*Listeria monocytogenes* is an ubiquitous, rapidly growing, Gram-positive bacterium with an unusually broad ecological niche and host range. Infection of humans and animals has been traced to contaminated foods and can lead to serious, often fatal disease. In humans, disease is most common among pregnant women, newborns, and immunocompromised individuals ([@bib42]).

Murine listeriosis has been studied for the past four decades to examine basic aspects of innate and acquired cellular immunity ([@bib36]; [@bib49]; [@bib17]; [@bib22]). Critical features of the murine model are that it is relatively rapid and quantitative, either by enumeration of colony forming units in the liver and spleen or by determination of a lethal dose. During experimental listeriosis, laboratory-grown bacteria are commonly injected in the tail vein and internalized by liver and splenic macrophages. In the liver, the majority of bacteria are killed by resident macrophages. Surviving bacteria grow in macrophages and spread into hepatocytes and form foci of infection that attract the influx of neutrophils and activated macrophages and resolve as granulomas. Mice that survive a sublethal dose of live bacteria acquire enhanced resistance to subsequent challenge. Acquired immunity is entirely cell mediated and largely dependent on cytotoxic CD8+ T-cells that recognize and lyse infected cells. Antibodies play little or no role in immunity, and administration of killed bacteria does not induce protective immunity, an observation with obvious implications for the development of vaccines to intracellular pathogens.

In vitro models of listeriosis
==============================

*L. monocytogenes* is particularly amenable to in vitro models of infection, as it enters and grows rapidly in a wide variety of tissue culture cells. However, as a facultative pathogen, it also grows in tissue culture media. To prevent extracellular replication, the aminoglycoside antibiotic gentamicin is added to infected cells subsequent to bacterial internalization. A relatively high concentration of gentamicin is bactericidal for extracellular bacteria, but has no measurable effect on intracellular wild-type *L. monocytogenes* during the first 8 h of infection ([@bib9]). Intracellular *L. monocytogenes* grow with initial doubling times of ∼40 min, which approximates the growth rate in rich media. Importantly, in most cells, intracellular growth continues without causing damage to host cells and, as will be discussed below, mutants that prematurely kill or damage host cells are avirulent. However, whereas cells infected with wild-type bacteria eventually die sometime after 8 h postinfection, bacteria rapidly spread to neighboring cells and thus propagate the infection ([Fig. 1](#fig1){ref-type="fig"}). Intracellular growth and cell-to-cell spread can be quantitated by measuring the diameter of macroscopic plaques that form in monolayers of cells. Plaque size has proven to be a good correlate of in vivo virulence ([@bib33]).

![**Stages in the intracellular life-cycle of** *Listeria monocytogenes.* (Center) Cartoon depicting entry, escape from a vacuole, actin nucleation, actin-based motility, and cell-to-cell spread. (Outside) Representative electron micrographs from which the cartoon was derived. LLO, PLCs, and ActA are all described in the text. The cartoon and micrographs were adapted from [@bib47].](200205009f1){#fig1}

*L. monocytogenes* enters almost all adherent cells, but the efficiency of uptake can vary over 10,000-fold. Macrophages and macrophage-like cell lines can internalize up to 20 bacteria per cell, whereas fibroblast cell lines internalize less than one bacterium per cell. However, significant levels of internalization by nonprofessional phagocytic cells is often mediated by one or more bacterial surface proteins, collectively named internalins, of which Internalin A and B are the best characterized ([@bib8]). Internalin A promotes binding and internalization by E-cadherin, whereas Internalin B binds to the Met receptor tyrosine kinase and mediates internalization via PI3-kinase activation ([@bib14]). The remainder of this review will focus on events that occur subsequent to internalization.

Escape from a vacuole
=====================

Upon phagocytosis by macrophages, there are a number of possible fates awaiting a bacterium ([@bib16]). In the case of *L. monocytogenes*, internalized bacteria are either killed or escape into the cytosol. Mutants that fail to escape from a vacuole may survive in tissue culture cell lines, but do not grow. The pore-forming protein listeriolysin O (LLO)[\*](#fn1){ref-type="fn"} is largely responsible for mediating escape from the vacuole, and is consequently an essential determinant of pathogenicity ([@bib50]). Mutants lacking LLO fail to escape from a vacuole in most cells, and synthesis of LLO by other organisms such as *Bacillus subtilis* is sufficient to mediate escape from a vacuole ([@bib6]). Thus, it is clear that the role of LLO is to mediate vacuolar escape from a phagosome and from a secondary vacuole formed upon cell-to-cell spread ([@bib18]).

In addition to LLO, *L. monocytogenes* secretes two phospholipases C (PLCs) that contribute to escape: a phosphatidylinositol-specific PLC (PI-PLC) and a broad-spectrum PLC (PC-PLC) that is synthesized as a proenzyme activated by a secreted *L. monocytogenes* metalloprotease ([@bib50]). Mutants lacking both PLCs show a marked defect in vacuolar escape, and in human epithelial cells such as HeLa cells, PC-PLC and metalloprotease mediate escape from a vacuole in the absence of LLO ([@bib32]).

The precise mechanism by which *L. monocytogenes* escapes from a vacuole is not clear but is consistent with the following model: upon phagocytosis, the *L. monocytogenes*--containing vacuole acquires markers of a maturing endosome/phagosome and acidifies to an average pH of 5.9 ([@bib1]; [@bib5]). Agents, such as bafilomycin that block acidification, inhibit vacuolar perforation and bacterial escape ([@bib13]; [@bib5]; [@bib20]). We propose that LLO insertion into the phagosomal membrane has two functions: one is to dissipate the pH gradient and thereby halt the maturation of the phagosome, and the other is act as a channel for the passage of proteins from the vacuole. The bacterial phospholipases and/or host vacuolar constituents then pass through the channel and act on the vacuole, leading to its dissolution. A direct role played by the host cell, if any, in mediating vacuolar dissolution is yet to be appreciated, although a host protease can activate PC-PLC during cell-to-cell spread ([@bib33]).

Compartmentalization of LLO activity
====================================

LLO is one of 22 members of the cholesterol-dependent family of cytolysins (CDCs) secreted by Gram-positive bacteria ([@bib48]). The best characterized of the CDCs are perfringolysin O (PFO) and streptolysin O, which are normally secreted by extracellular pathogens and presumably act on cells from outside. Replacement of LLO with PFO in *L. monocytogenes* results in a strain that is able to escape from a vacuole, albeit at a reduced efficiency, but that kills the infected cells from within ([@bib25]). Thus, LLO is apparently unique in that it acts in a vacuole, but does not kill the host cell upon growth in the cytosol. The properties of LLO as a vacuole-specific lysin can be exploited to deliver macromolecules to the cytosol of macrophages either by incorporation of LLO into acid sensitive liposomes or by expression of recombinant proteins in *Escherichia coli* expressing LLO ([@bib28]; [@bib23]).

One unique feature of LLO that contributes to its lack of toxicity is a PEST-like sequence near its NH~2~ terminus, rich in proline, glutamate, serine, and threonine residues ([Fig. 2](#fig2){ref-type="fig"}) ([@bib15]; [@bib29]). Removal of the PEST-like sequence does not affect LLO activity or vacuolar escape, but results in a strain that is extremely toxic to infected host cells and is 10,000-fold less virulent in mice. During in vitro infection, bacteria expressing the PEST-minus LLO permeabilize the host cell membrane after several bacterial generations, resulting in the influx of gentamicin and killing of the intracellular bacteria. Interestingly, most of the infected host cells apparently repair the LLO-mediated lesion and survive. In contrast, in the absence of gentamicin, intracellular PEST-minus bacteria continue to grow intracellularly and cause the rapid necrotic death of the infected host. Although it is tempting to assume that the PEST-like sequence is acting by targeting LLO for proteolytic degradation, the actual mechanism by which the PEST-like sequence acts to negate LLO toxicity is still not clear. However, the presence of three consensus mitogen-activated protein kinase sites ([Fig. 2](#fig2){ref-type="fig"}) suggests that it may be acting by interaction with host kinases. Mutation of the predicted phosphate acceptor residues results in a strain that is toxic to host cells and 100-fold less virulent ([@bib15]).

![**Schematic representation of sequences of interest within LLO.** The full length of the box represents the entire translated polypeptide of LLO expressed from the *hly* gene of *Listeria monocytogenes*. Shaded regions within the box represent stretches of amino acids of particular interest, but are not depicted to scale. The boundaries of the shaded regions are either indicated by the amino acid number directly above their depicted edge, or on either end of the detailed amino acid sequences contained within the region. MAPK consensus sites within and adjacent to the PEST-like sequence are underlined; NLS, a putative nuclear localization sequence, as predicted by the PSORTII program (<http://psort.nibb.ac.jp/>); PEST, the PEST-like region defined by PESTFind (<http://at.embnet.org/embnet/tools/bio/PESTfind/>), is represented as bold characters; SS, the signal sequence cleaved from the propeptide upon secretion; TMH1 and TMH2, transmembrane helixes discovered in PFO that pass through the target membrane upon pore formation ([@bib48]); UND, the conserved undecapeptide found in all cholesterol-dependent cytolysins. The mutation L461T increases hemolytic activity 10-fold at neutral pH ([@bib20]).](200205009f2){#fig2}

LLO is unique among the CDCs in that it has a pronounced acidic pH optimum. Mutation of a single LLO residue (L461T) results in an increase in LLO activity at neutral pH and leads to a 100-fold loss in virulence ([@bib20]). This mutation does not affect escape of *L. monocytogenes* from a vacuole, but causes premature permeabilization of infected host cells after about five bacterial generations. Thus, the acidic pH optimum of LLO, similar to the PEST-like sequence, restricts LLO activity to a vacuolar compartment.

Surprisingly, transcription and synthesis of LLO continues in the host cytosol ([@bib10]; [@bib35]). However, a number of other potential mechanisms may be in place to prevent toxicity to the infected host. For example, PC-PLC secretion is acid dependent and occurs preferentially in host vacuoles ([@bib31]), although this is yet to be documented for LLO. Another intriguing observation is that LLO contains a consensus dipartite nuclear localization signal ([Fig. 2](#fig2){ref-type="fig"}). Although it has not been examined experimentally, shuttling of LLO to the nucleus, which has very little membrane cholesterol, would be yet another mechanism to prevent LLO from breaching the cytoplasmic membrane. Clearly, a molecule as potentially toxic as LLO has multiple regulatory mechanisms to prevent damage to host cells.

Growth in the cytosol
=====================

Intracellular pathogens can be broadly divided into those that grow within a modified vacuole of the host cell ([@bib16]) and those like *L. monocytogenes* that grow in the host cytosol. There is compelling evidence to suggest that the cytosol is a favorable environment for bacterial growth: *Bacillus subtilis* expressing LLO or *E. coli* precoated with LLO can escape from a vacuole and grow in the cytosol of tissue culture cell lines ([@bib6]; [@bib34]). However, it was recently shown that an *L. monocytogenes* hexose phosphate transporter was virulence-regulated and necessary for growth on glucose-6-phosphate and optimal cytosolic growth ([@bib12]). Thus, although nonpathogens can grow in the cytosol under some circumstances, intracytosolic bacteria have clearly evolved specific mechanisms to enhance intracellular growth. In addition, as discussed below for *L. monocytogenes*, most intracytosolic bacterial pathogens have evolved mechanisms of actin-based motility to spread from cell to cell ([@bib21]). For a more detailed discussion of factors affecting cytosolic growth, see [@bib37].

Actin-based motility
====================

Shortly after entry into the mammalian cytosol, *L. monocytogenes* induces the polymerization of host actin filaments and uses the force generated by actin polymerization to move, first intracellularly and then from cell to cell ([Fig. 1](#fig1){ref-type="fig"}; for video images, see: <http://cmgm.stanford.edu/theriot/movies.htm>). Remarkably, a single bacterial protein, ActA, is responsible for mediating actin nucleation, actin-based motility, and is necessary for pathogenicity. ActA-minus mutants escape normally from vacuoles, but grow in the host cytosol as microcolonies and do not spread cell to cell or form plaques in tissue culture cell monolayers. The ActA protein provides multiple binding sites for host cytoskeletal components, thereby acting as a scaffold to assemble the cell\'s actin polymerization machinery ([@bib11]). The NH~2~ terminus of ActA binds to monomeric actin and acts as a constitutively active nucleation promoting factor by stimulating the intrinsic actin nucleation activity of the Arp2/3 complex by a mechanism similar to that proposed for host WASP family proteins ([@bib52]; [@bib39]; [@bib43]; [@bib7]; [@bib53]). Although ActA and WASP family proteins share little overall amino acid similarity, they do share a region that binds the Arp2/3 complex, referred to as the connector sequence that spans 15 residues containing the core sequence KKRRK. Mutations in this site confer an ActA-null phenotype in cells ([@bib39]; [@bib43]; [@bib7]; [@bib27]). ActA and WASP family proteins also share similarity in a short acidic stretch and both contain an actin binding region (WH2 region in WASP family proteins) that is unrelated.

The central region of ActA consists of three or four proline-rich repeats (consensus DFPPPPTDEEL) that bind the enabled/vasodilator-stimulated phosphoprotein (Ena/VASP) homology (EVH)1 domain of Ena/VASP family members with an affinity higher than that of all known EVH1 ligands such as vinculin and zyxin ([@bib40]). Ena/VASP family members are important for many actin-based processes including cell motility, platelet shape change, axon guidance, and T-cell activation ([@bib41]); however, a clear picture of their mechanistic role has yet to emerge. *L. monocytogenes* expressing ActA lacking Ena/VASP binding sites move more slowly in cells ([@bib26]; [@bib45]), and wild-type *L. monocytogenes* fail to move at all in cells microinjected with an excess of EVH1-binding peptides ([@bib46]). Paradoxically, fibroblasts lacking Ena/VASP proteins crawl faster than cells expressing Mena (mouse Ena) ([@bib3]). Ena/VASP proteins contain a proline-rich domain that binds profilin and an EVH2 domain that interacts with F-actin. Profilin specifically binds ATP monomeric actin and promotes actin polymerization from the barbed end of actin filaments ([@bib38]). Cells expressing Mena/VASP derivatives lacking profilin binding exhibit a decreased rate of *L. monocytogenes* motility but exhibit normal rates of cellular motility. In contrast, cells expressing Mena/VASP derivatives lacking the F-actin binding site move more rapidly than cells expressing wild-type Mena and support faster than wild-type rates of *L. monocytogenes* movement ([@bib19]; [@bib30]). However, in these cells, bacterial movement shows a significant difference in the directional persistence of actin-based motility resulting in less successful interaction with the cellular membrane and a corresponding decrease in plaque size (unpublished data). An explanation for these observations may be that Ena/VASP proteins, via their F-actin binding site, interact with the barbed ends of actin filaments and delay F-actin capping, resulting in longer, less branched actin filaments in vivo ([@bib4]) and in vitro ([@bib44]). Thus, the role of Ena/VASP proteins is to augment actin polymerization and to regulate the architecture of the actin filament network ([Fig. 3](#fig3){ref-type="fig"}). A possible explanation for Ena/VASP\'s effect on branching may relate to a recent paper showing that the Arp2/3 complex displays a branching preference at or near the barbed end ([@bib24]). Perhaps Ena/VASP\'s interaction with F-actin decreases the likelihood of Arp2/3-mediated branching.

![**Model of** *L. monocytogenes* **actin-based motility.** The eukaryotic Arp2/3 complex is activated by the NH~2~ terminus of the *L. monocytogenes* surface protein ActA ([@bib52]). ActA, Mena/VASP proteins, and profilin may all contribute to Arp2/3-mediated nucleation by delivering monomer to the complex. At this point, actin clouds can be observed around the bacterium. Once an actin filament is nucleated, profilin may increase elongation rates. The Arp2/3 complex caps the pointed ends of filaments and eventually dissociates from ActA. Mena/VASP proteins interact with the barbed ends of growing filaments and compete with capping protein ([@bib4]). Mena/VASP proteins (which bind ActA and barbed ends) remain concentrated at the bacterial-tail interface, whereas capping protein can be found throughout the tail. Rapidly growing barbed ends (protected from capping protein by Mena/VASP) are concentrated at the site necessary for force generation. At this point, the bacterium can be observed moving throughout the cytosol.](200205009f3){#fig3}

Immunological perspectives
==========================

One of the most striking results from the studies described above is that mutations in LLO that render strains prematurely cytotoxic are avirulent. Thus, just as it is commonly stated that successful pathogens have evolved to avoid killing their host, it is not beneficial for intracellular pathogens to kill their host cell. Indeed, the host has evolved innate and acquired mechanisms, including induction of apoptosis and the generation of antigen-specific cytotoxic T-cells, that result in killing of infected cells ([@bib22]). Lysis by cytotoxic T-cells is an important acquired immunological effector mechanism to eliminate *L. monocytogenes* ([@bib17]). This may provide an explanation for the observations that *L. monocytogenes* cytotoxic mutants are avirulent: premature killing of infected host cells may lead to extracellular bacteria that are readily killed by infiltrating phagocytes. This also provides a framework with which to understand why *L. monocytogenes* spreads from cell to cell; i.e., to avoid cytotoxic T-cells and phagocytes. Consistent with this notion, *L. monocytogenes* mutants that cannot recruit Ena/VASP peoteins show a small virulence defect in naïve mice, but show a 400-fold virulence defect in the liver of immune mice ([@bib2]) and (unpublished data). Presumably, efficient cell-to-cell spread is necessary during a cellular immune response. Lastly, it should be noted that an immunodominant epitope recognized by *Listeria*-immune cytotoxic T-cells is derived from LLO ([@bib51]). Perhaps the fail-safe properties of LLO that are necessary for pathogenesis, such as rapid degradation in the cytosol, also lead to entry of LLO into the host\'s cytosolic pathway of antigen processing and presentation. Thus, LLO lies at the interface of bacterial pathogenesis and cell-mediated immunity.
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